10X Genomics Inc Strategic Asset Allocation Index
10X Genomics Inc strategic asset allocation index. 10X Genomics Inc (TXG) has a Strategic Asset Allocation Index of 47.5% as of September 2023. Strategic assets (PP&E of $354.20 Million plus long-term investments of $-) total $354.20 Million, measured against net assets of $745.22 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check TXG tangible net worth ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of 10X Genomics Inc (2019–2022)
Strategic asset allocation index of 10X Genomics Inc from 2019 to 2022. This chart shows how 10X Genomics Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of September 2023, the index stands at 47.5%, representing strategic assets of $354.20 Million against net assets of $745.22 Million USD.
10X Genomics Inc Strategic Asset Allocation Index by Year (2019–2022)
10X Genomics Inc strategic asset allocation index by year from 2019 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for 10X Genomics Inc from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 10X Genomics Inc stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 35.9% | $289.33 Million | $289.33 Million | $- | $805.74 Million | ▲ +7.7 pp |
| 2021 | 28.2% | $230.41 Million | $230.41 Million | $- | $817.57 Million | ▲ +18.3 pp |
| 2020 | 9.9% | $72.84 Million | $72.84 Million | $- | $739.07 Million | ▼ -1.8 pp |
| 2019 | 11.6% | $48.82 Million | $48.82 Million | $- | $420.08 Million | — |